BRIEF published on 03/09/2026 at 07:35, 17 days 3 hours ago GenSight Biologics : Point sur les Programmes d'Accès Précoce et l'Étude REVISE Thérapie Génique GenSight Biologics Neuropathie Optique Étude REVISE Accès Précoce
BRIEF published on 03/09/2026 at 07:35, 17 days 3 hours ago GenSight Biologics fait le point sur ses programmes d'accès précoce et l'étude REVISE GenSight Biologics Neuropathie Optique Héréditaire De Leber GS010/LUMEVOQ® Étude REVISER Programmes D'accès Anticipé
BRIEF published on 03/09/2026 at 07:35, 17 days 3 hours ago GenSight Biologics: Update on Early Access Programs and the REVISED Study Gene Therapy GenSight Biologics Early Access Optic Neuropathy REVISED STUDY
BRIEF published on 03/09/2026 at 07:33, 17 days 3 hours ago UBS Releases 2025 Annual Report Sustainability Goals Financial Performance UBS 2025 Report Credit Suisse Integration Net-zero Ambitions
BRIEF published on 03/09/2026 at 07:33, 17 days 3 hours ago UBS publie son rapport annuel 2025 Performance Financière Objectifs De Développement Durable Rapport UBS 2025 Intégration De Credit Suisse Ambitions Zéro Émission Nette
BRIEF published on 03/09/2026 at 07:17, 17 days 3 hours ago Heidelberg Pharma Amends Royalty Agreement with HealthCare Royalty and Soleus Capital Joins FDA Approval Heidelberg Pharma Royalty Agreement Soleus Capital Biotech Investment
BRIEF published on 03/09/2026 at 07:17, 17 days 3 hours ago Heidelberg Pharma modifie son accord de redevances avec HealthCare Royalty et Soleus Capital se joint à la procédure. Heidelberg Pharma Approbation De La FDA Soleus Capital Investissement En Biotechnologie Contrat De Redevances
BRIEF published on 03/09/2026 at 07:05, 17 days 4 hours ago Ringmetall Acquires Makplast to Expand Liner Operations in Turkey Growth Strategy Ringmetall Makplast Liner Manufacturer Turkey Acquisition
BRIEF published on 03/09/2026 at 07:05, 17 days 4 hours ago Ringmetall acquiert Makplast pour développer ses activités de production de revêtements en Turquie Stratégie De Croissance Ringmetall Makplast Fabricant De Doublures Acquisition De La Turquie
BRIEF published on 03/09/2026 at 06:20, 17 days 4 hours ago OPPO Finds New Foldable Zeros Crease Technology with Find N6 Launch Smartphone Launch Foldable Technology OPPO Find N6 Zero-Feel Crease AI Pen
Published on 03/26/2026 at 11:07, 10 minutes ago U.S. Mined and Refined Metals as well as Rare Earth Elements to Be Tokenized in Historic American Strategic Minerals and Datavault AI Deal
Published on 03/26/2026 at 11:00, 17 minutes ago Stagwell Expands the Harris Poll's Harrisquest Across Europe
Published on 03/26/2026 at 08:05, 3 hours 12 minutes ago Vanta Announces U.S. Ticker Symbol Change to VNTXF
Published on 03/26/2026 at 04:55, 6 hours 22 minutes ago Vanta Announces Capital Markets Initiatives to Strengthen Financial Position and Support Growth Initiatives
Published on 03/26/2026 at 11:03, 14 minutes ago EQS-Adhoc: VIDINEXT AG: Marketing agreement with Telekom Deutschland GmbH
Published on 03/26/2026 at 11:00, 17 minutes ago Genel Energy PLC: Posting of Annual Report and Notice of AGM
Published on 03/26/2026 at 11:00, 17 minutes ago Genel Energy PLC: Report on payments to governments for the year 2025
Published on 03/26/2026 at 11:00, 17 minutes ago ABB Ltd: ABB share buybacks - March 19, 2026 - March 25, 2026
Published on 03/26/2026 at 11:00, 17 minutes ago Une étude indépendante révèle un retour sur investissement de 44 % avec EQS Compliance Cockpit et un amortissement en moins de six mois.
Published on 03/26/2026 at 07:30, 3 hours 47 minutes ago BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
Published on 03/26/2026 at 07:30, 3 hours 47 minutes ago BIOPHYTIS ET LYNXKITE INVITÉS À LA CONFÉRENCE NVIDIA : L’IA AU SERVICE DE LA LONGÉVITÉ
Published on 03/25/2026 at 18:53, 16 hours 23 minutes ago CIS - Transfert Contrat de Liquidité Portzamparc - 25.03.2026
